Temporary Left Ventricular Assist Devices: Indications and Patient Selection.
DV, B. & SV, M. (2026). Temporary Left Ventricular Assist Devices: Indications and Patient Selection.. Clinics in chest medicine. https://doi.org/10.1016/j.ccm.2026.04.013
DV B, SV M. Temporary Left Ventricular Assist Devices: Indications and Patient Selection.. Clinics in chest medicine. 2026; doi: 10.1016/j.ccm.2026.04.013
DV B, SV M. Temporary Left Ventricular Assist Devices: Indications and Patient Selection.[J]. Clinics in chest medicine. 2026. DOI: 10.1016/j.ccm.2026.04.013.
@article{dv2026,
author = {Balanescu DV and Mankad SV},
title = {Temporary Left Ventricular Assist Devices: Indications and Patient Selection.},
journal = {Clinics in chest medicine},
year = {2026},
doi = {10.1016/j.ccm.2026.04.013},
note = {PMID: 42486567},
}
TY - JOUR AU - Balanescu DV AU - Mankad SV TI - Temporary Left Ventricular Assist Devices: Indications and Patient Selection. T2 - Clinics in chest medicine PY - 2026 DO - 10.1016/j.ccm.2026.04.013 AN - PMID:42486567 ER -
Temporary percutaneous left ventricular assist devices (pLVADs), most prominently transvalvular microaxial flow pumps, have become central tools for contemporary cardiogenic shock care and for hemodynamic protection during selected high-risk percutaneous coronary interventions. Their value, however, is determined far more by patient selection and timing than by device capability alone. This article frames pLVAD use as a high-stakes triage decision anchored in shock phenotype, trajectory, reversibility, and an explicit exit strategy (bridge-to-recovery, bridge-to-decision, bridge-to-transplant, or bridge-to-durable left ventricular assist device).